This content is machine translated Atopic Dermatitis: Precisely Targeting Immunological Targets Interleukin blockade or OX40-(L) inhibition? The pathogenesis of atopic dermatitis (AD) involves a complex cascade that occurs at various levels. Immunomodulatory antibody therapies have been developed for the treatment of moderate-to-severe AD; these therapies interfere...…
View Post 27 min This content is machine translated Across All Types of Cancer Four-Legged Medical Assistants – Therapy Dogs in Clinical Settings Animal-assisted interventions are becoming increasingly important in oncology, palliative care, and pediatrics, as they promote emotional stability, a sense of connection, and psychosocial relief. Swiss hospitals such as those in...… CME-Test
View Post 8 min This content is machine translated Obesity: More than half of those affected have fatty liver disease From screening to multimodal intervention with GLP-1-RA or resmetirom Metabolic dysfunction-associated steatotic liver disease ( MASLD) is one of the most common complications of obesity and diabetes. If fatty liver disease is not addressed through lifestyle changes and, if...…
View Post 6 min This content is machine translated Innovative Oral Treatment Options for Psoriasis: Icotrokinra and Zasocitinib First-class immunomodulation combined with convenience—the data available so far is convincing Our understanding of the pathophysiology of psoriasis has improved significantly in recent years, and numerous therapeutic targets have been identified. This has recently led to the development of innovative active...…
View Post 4 min This content is machine translated Preclinical Study on a Special Ginkgo biloba Extract What role do proanthocyanidins play? In a laboratory study published in 2025, proanthocyanidins (PACs) were isolated from the specialized ginkgo extract EGb 761® and evaluated using in vitro and in vivo assays in combination with...…
View Post 6 min This content is machine translated Myasthenia gravis: immunomodulatory therapies for long-term treatment Expanded Possibilities Thanks to Innovative Classes of Active Ingredients Myasthenic syndromes result from a disturbance in neuromuscular transmission. Although there is still no curative treatment for myasthenia gravis, the drug treatment options available today offer tailored therapeutic approaches aimed...…
View Post 13 min This content is machine translated Two years of controlled data, two suppression strategies, and the risks associated with discontinuation Uterus myomatosus and heavy menstrual bleeding: oral GnRH antagonists Uterine fibroids are the most common tumors of the female reproductive organs, but only about one-quarter of affected women develop symptoms that require treatment. The most common symptoms are heavy...…
View Post 10 min This content is machine translated Interstitial Lung Diseases Update on Idiopathic Pulmonary Fibrosis Interstitial lung diseases (ILDs) encompass more than 100 conditions. They represent a heterogeneous group of acute or chronic lung diseases that are characterized—to varying degrees—by inflammation and uncontrolled connective tissue...… CME-Test
View Post 9 min This content is machine translated What the StepUp study changes and what has long been included in the guidelines Bacterial Vaginosis: Treatment for Partners and Prevention of Recurrence Acute treatment for bacterial vaginosis has been established for decades and is reliably effective. The clinical problem begins afterward. A large proportion of women experience a recurrence within a few...…
View Post 10 min This content is machine translated From a 10-Year Risk to a 3-Year Risk Bone Health After Menopause and During Endocrine Therapy The figures for Switzerland are well known, yet they are still underestimated: One in two women and one in five men suffer a fragility fracture after the age of 50....…
View Post 7 min This content is machine translated Ischemic stroke: Are smaller or larger brain arteries affected? Recent study findings on intravenous lysis therapy with fibrinolytic agents Intravenous thrombolysis, with or without mechanical thrombectomy, is a key pillar in the treatment of ischemic stroke. There are now two approved treatment options available—alteplase and tenecteplase—and Phase II data...…
